TSP1293-CMap - NLT_B: Toxicogenomic signatures after exposure to tamoxifen


TSA9811-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen


TSA9821-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen


TSF13853-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.39 µM


1 subfactor(s)
TSF13854-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.2 µM


1 subfactor(s)
TSF13847-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 24.98 µM


1 subfactor(s)
TSF13848-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 12.46 µM


1 subfactor(s)
TSF13849-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 6.24 µM


1 subfactor(s)
TSF13850-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 3.12 µM


1 subfactor(s)
TSF13855-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.1 µM


1 subfactor(s)
TSF13851-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 1.6 µM


1 subfactor(s)
TSF13852-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.8 µM


1 subfactor(s)
TSF13856-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.05 µM


1 subfactor(s)
TSF13923-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 49.99 µM


1 subfactor(s)
TSF13957-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 24.98 µM


1 subfactor(s)
TSF13963-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.39 µM


1 subfactor(s)
TSF13958-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 12.46 µM


1 subfactor(s)
TSF13959-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 6.24 µM


1 subfactor(s)
TSF13960-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 3.12 µM


1 subfactor(s)
TSF13961-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 1.6 µM


1 subfactor(s)
TSF13962-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.8 µM


1 subfactor(s)
TSF13964-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.2 µM


1 subfactor(s)
TSF13965-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.1 µM


1 subfactor(s)
TSF13966-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.05 µM


1 subfactor(s)
TSS13856-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.39 µM


TSS13857-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.2 µM


TSS13850-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 24.98 µM


TSS13851-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 12.46 µM


TSS13852-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 6.24 µM


TSS13853-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 3.12 µM


TSS13858-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.1 µM


TSS13854-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 1.6 µM


TSS13855-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.8 µM


TSS13859-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.05 µM


TSS13926-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 49.99 µM


TSS13960-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 24.98 µM


TSS13966-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.39 µM


TSS13961-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 12.46 µM


TSS13962-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 6.24 µM


TSS13963-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 3.12 µM


TSS13964-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 1.6 µM


TSS13965-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.8 µM


TSS13967-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.2 µM


TSS13968-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.1 µM


TSS13969-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.05 µM



TSP1293 - CMap - NLT_B: Toxicogenomic signatures after exposure to tamoxifen Public


https://clue.io/data/NLT#NLT_B

Experimental design


No experimental design provided

Results


No results provided